Evidence map›Paper›PMID 12213718›Full record

ArticleThe American journal of pathology2002

Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle.

Yong Li, Johnny Huard

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05637216 (A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients), which is not on this map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05637216 phase2active not recruitingnot on this mapstarted 2023, after this paper: background citation

A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

TypeinterventionalSponsorShaw Cancer CenterRan2023 to 2027Enrolled43ConditionsRadiation Induced FibrosisArmsLosartan 25 milligram capsule, Placebo
3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 239 citations in OpenAlex.

  1. PrPJournal of cachexia, sarcopenia and muscle · 2025
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Stem Cell and Macrophage Roles in Skeletal Muscle Regenerative Medicine.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Muscle stem cells: what's new in orthopedics?Acta bio-medica : Atenei Parmensis · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Perivascular cell αv integrins as a target to treat skeletal muscle fibrosis.The international journal of biochemistry & cell biology · 2018
    Article
  20. Immunology Guides Skeletal Muscle Regeneration.International journal of molecular sciences · 2018
    Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yong LiDepartment of Orthopaedic Surgery, Growth and Development Laboratory, Children's Hospital of Pittsburgh, Pennsylvania 15213-2583, USA.
Johnny Huard
University of Pittsburgh · US

Funding

IMPROVING MUSCLE HEALING THROUGH PREVENTION OF FIBROSISR01AR047973 · NIAMS · CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS · PI HUARD, JOHNNY · 2001 to 2004
$1.1M
NIAMS NIH HHS 1R01 AR47973-01NIAMS NIH HHS R01 AR047973
6 · The paper itself

Abstract

Injured muscle can initiate regeneration promptly by activating myogenic cells that proliferate and differentiate into myotubes and myofibers. However, the recovery of the injured skeletal muscle often is hindered by the development of fibrosis. We hypothesized that the early-appearing myogenic cells in the injured area differentiate into myofibroblasts and eventually contribute to the development of fibrosis. To investigate this, we transplanted a genetically engineered clonal population of muscle-derived stem cells (MC13 cells) into the skeletal muscle of immunodeficient SCID mice, which were lacerated 4 weeks after transplantation. The MC13 cells regenerated numerous myofibers in the nonlacerated muscle and these myogenic cells were gradually replaced by myofibroblastic cells in the injured muscle. Our results suggest that the release of local environmental stimuli after muscle injury triggers the differentiation of myogenic cells (including MC13 cells) into fibrotic cells. These results demonstrate the potential of muscle-derived stem cells to differentiate into different lineages and illustrate the importance of controlling the local environment within the injured tissue to optimize tissue regeneration via the transplantation of stem cells.

Indexed as

AnimalsCell DifferentiationCell LineageFibroblastsMiceMice, SCIDMuscle, SkeletalRegenerationStem CellsStem Cell TransplantationTissue Engineering

Identifiers

PMID12213718
PMCPMC1867256
OpenAlexW2061827083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.